{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T16:02:01Z","timestamp":1756310521418,"version":"3.40.5"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00277-020-04211-2","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T08:03:57Z","timestamp":1597651437000},"page":"2647-2648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HHV-8 negative PEL-like lymphoma follicular helper T type in a non-HIV infected elderly"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0712-0083","authenticated-orcid":false,"given":"Keisuke","family":"Kidoguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumi","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Tokushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Monji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Shimasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"4211_CR1","first-page":"323","volume-title":"World Health Organization classification of tumors of haematopoietic and lymphoid tissues","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) (2017) World Health Organization classification of tumors of haematopoietic and lymphoid tissues. IRAC Press, Lyon, pp 323\u2013324"},{"issue":"18","key":"4211_CR2","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1182\/blood-2018-03-791426","volume":"132","author":"K Shimada","year":"2018","unstructured":"Shimada K, Hayakawa F, Kiyoi H (2018) Biology and management of primary effusion lymphoma. Blood 132(18):1879\u20131888. https:\/\/doi.org\/10.1182\/blood-2018-03-791426","journal-title":"Blood"},{"issue":"2","key":"4211_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/PAS.0b013e318267fabc","volume":"37","author":"S Alexanian","year":"2013","unstructured":"Alexanian S, Said J, Lones M, Pullarkat ST (2013) KSHV\/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states. Am J Surg Pathol 37(2):241\u2013249. https:\/\/doi.org\/10.1097\/PAS.0b013e318267fabc","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4211_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/10428190400018364","volume":"46","author":"Y Matsumoto","year":"2009","unstructured":"Matsumoto Y, Nomura K, Ueda K, Satoh K, Yasuda N, Taki T, Yokota S, Horiike S, Okanoue T, Taniwaki M (2009) Human herpesvirus 8-negative malignant effusion lymphoma: a distinct clinical entity and successful treatment with rituximab. Leuk Lymphoma 46(3):415\u2013419. https:\/\/doi.org\/10.1080\/10428190400018364","journal-title":"Leuk Lymphoma"},{"key":"4211_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00277-017-3200-x","volume":"97","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi T, Mori D, Ureshino H, Kido S, Ikeda S, Kimura S, Lefor AK, Matsuishi E (2018) Primary effusion lymphoma-like lymphoma with a T cell phenotype. Ann Hematol 97:717\u2013718. https:\/\/doi.org\/10.1007\/s00277-017-3200-x","journal-title":"Ann Hematol"},{"key":"4211_CR6","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3389\/fimmu.2018.01924","volume":"9","author":"DA Rao","year":"2018","unstructured":"Rao DA (2018) T cells that help B cells in chronically inflamed tissues. Front Immunol 9:1924. https:\/\/doi.org\/10.3389\/fimmu.2018.01924","journal-title":"Front Immunol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04211-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04211-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04211-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T08:10:30Z","timestamp":1631607030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04211-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4211"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04211-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Koichi Ohshima has received lecturer fees from Chugai company. Koichi Ohshima has received research expenses from Kyowa-Kirin company, Chugai company, Celgene company, and Daiichi Sankyo. Koichi Ohshima has received fees of testimony, judgment, and comment from SRL company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}